Clinical Trial
-
Spine
Mainstay Medical Announces Publication of Two-Year Patient Outcomes Data from ReActiv8-B Clinical Trial Demonstrating Long-Term Efficacy of ReActiv8® Restorative Neurostimulation™
Data shows compelling efficacy and safety, as well as improvement on all key measures of pain and disability as compared…
Read More » -
Spine
BioRestorative Therapies Announces CRO Agreement with PRC Clinical for its BRTX-100 Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease
MELVILLE, N.Y., Dec. 21, 2021 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ:BRTX), a life sciences company…
Read More » -
Biologics
Ortho Regenerative Technologies Announces U.S. IND Clinical Hold Lifted By The FDA & Clearance To Proceed With U.S. Clinical Trial
MONTREAL, Dec. 13, 2021 /PRNewswire/ – Ortho Regenerative Technologies Inc. (CSE: ORTH) (OTCQB: ORTIF) (“Ortho” or the “Company”), a clinical-stage orthobiologics company focused on the…
Read More » -
Hospitals
HSS and Rothman Institute/Jefferson University Hospital to Participate in Clinical Trial for Elute’s Antibiotic Loaded Bone Void Filler
SALT LAKE CITY, Nov. 30, 2021 /PRNewswire/ — Following Elute, Inc.’s Investigational Device Exemption (IDE) authorization from the US Food and Drug Administration (FDA)…
Read More » -
Biologics
Ortho Regenerative Technologies Receives Clinical Hold Letter From the U.S. FDA
Additional CMC related data and characterization requested by the FDACompany confident of providing requested information over the coming weeksPhase I/II…
Read More » -
Neuro
ADR Spinal Restoration Center Opens Up 2-Level prodisc® and 1-Level Synergy Disc® Clinical Trials in Los Angeles
LOS ANGELES (PRWEB) MAY 21, 2021 Those suffering from painful degenerative or herniated discs in their necks might find relief in…
Read More » -
Spine
Synergy Disc® Announces Enrollment of First Patient in US IDE Clinical Trial
January 29, 2021 LOUISVILLE, Colo.–(BUSINESS WIRE)–Synergy Disc Replacement Ltd., a Colorado-based spinal medical device company and wholly owned subsidiary of…
Read More » -
Recon
LimaCorporate Announces FDA Approval for an Ide Study on Smr Stemless Reverse Shoulder System
UDINE, Italy, Nov. 19, 2020 /PRNewswire/ — LimaCorporate is proud to announce that the U.S. Food and Drug Administration (FDA) has approved the…
Read More » -
Biologics
Bioventus Receives Authorization to Proceed Under Investigational New Drug Application for Clinical Trial of Placental Tissue Particulate (PTP-001) for the Treatment of Knee OA
November 18, 2020 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a leader in Solutions For Innovative Healing, received authorization to proceed under its investigational…
Read More » -
Spine
One-Year Outcomes Data from the OptiMesh® SCOUT (Spineology® Clinical Outcomes Trial) IDE (Investigational Device Exemption) Published in SPINE
The OptiMesh® Expandable Interbody Fusion System demonstrates significant reduction in pain, improvement in back function, and high patient-satisfaction scores November 17,…
Read More » -
COVID-19
NYU Langone Health to Enroll Healthy Volunteers In Clinical Trial for COVID-19 Vaccine
NEW YORK, Nov. 11, 2020 /PRNewswire/ — NYU Grossman School of Medicine is among the centers enrolling participants in a randomized phase…
Read More » -
Extremities
Avanos Medical, Inc. Announces Publication of Clinical Trial Demonstrating Superiority of COOLIEF* over Hyaluronic Acid Injections for the Management of Chronic Knee Pain
ALPHARETTA, Ga., Sept. 3, 2020 /PRNewswire/ — Avanos Medical, Inc. (NYSE: AVNS) today announced the publication of a large, randomized, multicentered clinical trial comparing…
Read More » -
COVID-19
Single Dose of Johnson & Johnson COVID-19 Vaccine Candidate Demonstrates Robust Protection in Pre-clinical Studies
NEW BRUNSWICK, N.J., July 30, 2020 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) (the Company) today announced that its lead vaccine candidate protected against…
Read More » -
Extremities
Mayo TJA Study: Mepivacaine=More Consistent Return of Motor Function Versus Low-Dose Bupivacaine
by Elizabeth Hofheinz, M.P.H., M.Ed. While spinal anesthesia confers benefits when administered during primary total hip arthroplasty (THA) and total…
Read More » -
Biologics
Cerapedics Announces FDA approval of an IDE supplement
WESTMINSTER, Colo., July 22, 2020 — Cerapedics, a private ortho-biologics company, today announced the U.S. Food and Drug Administration (FDA)…
Read More »